Committed to responsible pain management
Developing innovative and differentiated products for people suffering from pain
At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate to severe pain.
News and Press
Collegium Announces Closing of the Nucynta Franchise AcquisitionRead More February 13, 2020
Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes OfferingRead More February 11, 2020